When was abecma approved?

When did Abecma (idecabtagene vicleucel) get FDA approval?

Abecma was approved by the U.S. Food and Drug Administration (FDA) on March 26, 2021. [1]

What was the first approval for (and for whom)?

That FDA approval was for adults with relapsed or refractory multiple myeloma who had received at least four prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 monoclonal antibody. [1]

Where can I verify the approval date?

DrugPatentWatch lists the FDA approval date for Abecma as March 26, 2021. [1]

Sources

1. DrugPatentWatch.com – ABECMA (idecabtagene vicleucel) FDA Approval Date